28169-46-2Relevant articles and documents
Preparation method of 3, 5-dinitro-2-methylbenzoic acid
-
Paragraph 0022-0051, (2021/07/24)
The invention discloses a preparation method of 3, 5-dinitro-2-methylbenzoic acid. The preparation method comprises the following steps: carrying out nitration reaction on o-toluic acid and nitrite in a mixed solvent of an organic solvent and water under the action of visible light by utilizing a supported photocatalyst, and carrying out post-treatment after the reaction is ended, thereby obtaining the 3, 5-dinitro-2-methylbenzoic acid. The method has the characteristics that the raw materials are easy to obtain, the reaction conditions are mild and easy to control, the catalyst can be recycled, the yield is high, and the method is relatively environment-friendly, and has important application significance.
Synthesis method of zoalene
-
Paragraph 0027, (2016/11/28)
The invention discloses a synthesis method of zoalene, belonging to the technical field of pharmaceutical engineering. The method comprises the following steps: A. nitration process, B. acylating chlorination process, and C. ammonifying process, wherein in the step A, a process of recycling concentrated sulfuric acid is set, specifically, the collected waste acid is treated by reduced pressure distillation and is concentrated, sulfur trioxide is then added into the treated waste acid, and the newly prepared concentrated sulfuric acid is added into a reaction kettle again for carrying out a nitration reaction; in the step C, a process of recycling waste ammonia water is set. By recycling and reusing raw materials, the method does not cause accumulative increment of sulfuric acid and ammonia water, thus improving the utilization rate of the raw materials and lowering the production cost; furthermore, the method reduces the treatment cost of the waste acid and the waste ammonia water and greatly reduces the discharge amount of waste water, thus having an important significance for environmental protection.
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Page/Page column 0438; 1777, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.